Supplementary data-Intra-vaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. 2018.pdf (68.26 kB)
0/0

Supplementary data-Intra-vaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. 2018.pdf

Download (68.26 kB)
dataset
posted on 04.08.2018 by Susan Davis
This table reports the clinician reported assessment outcomes for intra-vaginal testosterone vs placebo over 26 weeks in women taking an aromatase inhibitor

Funding

Accelerator Grant of the National Breast Cancer Foundation (Australia) Grant no: NT-16-006

History

Licence

Exports

Categories

Licence

Exports